Cargando…
Author Correction: Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
Autores principales: | AlShamaileh, Hadi, Wang, Tao, Xiang, Dongxi, Yin, Wang, Tran, Phuong Ha-Lien, Barrero, Roberto A., Zhang, Pei-Zhuo, Li, Yong, Kong, Lingxue, Liu, Ke, Zhou, Shu-Feng, Hou, Yingchun, Shigdar, Sarah, Duan, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733483/ https://www.ncbi.nlm.nih.gov/pubmed/33311517 http://dx.doi.org/10.1038/s41598-020-77490-4 |
Ejemplares similares
-
Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells
por: AlShamaileh, Hadi, et al.
Publicado: (2017) -
EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model
por: Wang, Tao, et al.
Publicado: (2015) -
Aptamers as Theranostic Agents: Modifications, Serum Stability and Functionalisation
por: Shigdar, Sarah, et al.
Publicado: (2013) -
Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
por: Xiang, Dongxi, et al.
Publicado: (2017) -
Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures
por: Rahimizadeh, Kamal, et al.
Publicado: (2017)